Atara Biotherapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Atara Biotherapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Atara Biotherapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Atara Biotherapeutics Inc. is ATRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Atara Biotherapeutics Inc. has its primary listing on NASDAQ. You can trade Atara Biotherapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Atara Biotherapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Atara Biotherapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Atara Biotherapeutics Inc..